Answers are grounded in this paper and cite their sources.
Long-term prospective study highlights symptom variability in endometriosis, suggesting improved healthcare communication.
Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by highly individualized, multisystemic symptoms, affecting approximately 10% of females. In this work, we present a long-term prospective study in which 34 participants defined personalized symptom sets and severity scales, tracking them daily for up to 12 months using a custom-developed app. This patient-tailored, high-resolution monitoring revealed substantial heterogeneity in the number of symptoms tracked, with participants tracking a median of 24.5 unique symptoms (interquartile range [19.25, 36.5]). To standardize assessment of system-organ involvement, symptoms were mapped to the MedDRA hierarchy, allowing structured analysis of symptom distribution. Based on these data, we propose a framework for characterizing symptom burden, trajectory, and disease burden, concepts that together capture the variability, systemic nature, and complexity of endometriosis. This personalized approach offers a clearer understanding of the disease experience and lays the groundwork for future tools that may improve communication with healthcare providers and inform more personalized and effective treatment strategies.
No takes yet. Share an insight, caveat, or question.
Zelovich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: